![Hing Wong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hing Wong
Oprichter bij
HCW BIOLOGICS INC.
Vermogen: 203 211 $ op 31-05-2026
Profiel
Hing C.
Wong was the founder of Altor BioScience Corp., founded in 2002, serving as President, Chief Executive Officer & Director from 2012 to 2017.
Dr. Wong was the founder of Sunol Molecular Corp., founded in 1996, serving as Chairman & Chief Executive Officer from 1996 to 2002.
Dr. Wong is the founder of HCW Biologics Inc., founded in 2018, serving as Chief Executive Officer, Secretary & Director since 2018.
Former jobs include Chief Executive Officer at NantCell, Inc. from 2017 to 2018; Director-Biology Skills Center at Baxter International, Inc. from 1992 to 1996; Director-Microbial Genetics Department at Chiron Corp.
from 1983 to 1992; Director-Microbial Genetics at Cetus Corp.
from 1983 to 1992; Director at Biosynexus, Inc.; Trustee at The Cancer Research Foundation, Inc.; and Trustee at Rumbaugh-Goodwin Institute For Cancer Research, Inc. Education includes a doctorate from the University of Massachusetts.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
HCW BIOLOGICS, INC. 1,52% | 22-05-2026 | 102.632 ( 1,52% ) | 203 211 $ | 31-05-2026 |
Actieve functies van Hing Wong
| Bedrijven | Functie | Begin |
|---|---|---|
| HCW BIOLOGICS INC. | Oprichter | 02-04-2018 |
Eerdere bekende functies van Hing Wong
| Bedrijven | Functie | Einde |
|---|---|---|
NantCell, Inc.
 NantCell, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic diseases | Algemeen Directeur | 01-03-2018 |
Altor BioScience Corp.
 Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer | Oprichter | 01-08-2017 |
Sunol Molecular Corp.
 Sunol Molecular Corp. Pharmaceuticals: MajorHealth Technology Develops gel therapeutics to treat disorders associated with the human tissue factor | Algemeen Directeur | 01-01-2002 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01-01-1996 |
Cetus Corp.
 Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01-01-1992 |
Opleiding van Hing Wong
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
67
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Altor BioScience Corp.
Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer | Health Technology |
Cetus Corp.
Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Sunol Molecular Corp.
Sunol Molecular Corp. Pharmaceuticals: MajorHealth Technology Develops gel therapeutics to treat disorders associated with the human tissue factor | Health Technology |
The Cancer Research Foundation, Inc.
 The Cancer Research Foundation, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Rumbaugh-Goodwin Institute For Cancer Research, Inc. | |
NantCell, Inc.
NantCell, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic diseases | Health Technology |
HCW Biologics Inc.
 HCW Biologics Inc. BiotechnologyHealth Technology Develops immunotherapies for chronic, low-grade inflammation and age related disorders | Health Technology |
Kies MarketScreener 
